Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yatiri Bio
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Yatiri Bio has developed proteomics-driven, machine learning-based models (ProteoModels) for patient stratification and therapeutic matching in oncology, with initial focus on acute myeloid leukemia and ovarian cancer. Clinical validation using these tools with Fred Hutch Cancer Center is expected to begin by the end of the year[2].
- Therapeutic areas
- OncologyHematology
- Modalities
- Small moleculeProteinBiologic
- Industry
- Digital Health Medical Devices
02
Partnerships
Fred Hutch Cancer CenterMD AndersonSharp HealthCareScripps ResearchJapanese Foundation for Cancer Research
Beyond the preview
Go deeper on Yatiri Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yatiri Bio.